Tessa Knox

1.3k total citations
18 papers, 861 citations indexed

About

Tessa Knox is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tessa Knox has authored 18 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tessa Knox's work include Histone Deacetylase Inhibitors Research (14 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (5 papers). Tessa Knox is often cited by papers focused on Histone Deacetylase Inhibitors Research (14 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (5 papers). Tessa Knox collaborates with scholars based in United States, Czechia and Chile. Tessa Knox's co-authors include Alejandro Villagra, Alan P. Kozikowski, Oleg S. Gorbatyuk, Alfred S. Lewin, Matthew M. LaVail, Nicholas Muzyczka, Marina S. Gorbatyuk, William W. Hauswirth, Jonathan H. Lin and Syed M. Noorwez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Tessa Knox

18 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tessa Knox United States 9 606 256 118 112 102 18 861
Sunnie Wong United States 9 831 1.4× 184 0.7× 47 0.4× 45 0.4× 64 0.6× 14 1.1k
Rita Bisogni Italy 14 502 0.8× 192 0.8× 239 2.0× 60 0.5× 17 0.2× 25 868
Erin L. Filbert United States 7 284 0.5× 84 0.3× 172 1.5× 84 0.8× 13 0.1× 19 526
Martha Delahunty United States 12 353 0.6× 46 0.2× 116 1.0× 68 0.6× 8 0.1× 19 663
Manuela Bragardo Italy 15 246 0.4× 144 0.6× 550 4.7× 48 0.4× 21 0.2× 19 934
N. J. Philpott United Kingdom 10 339 0.6× 119 0.5× 186 1.6× 28 0.3× 22 0.2× 14 703
E A Gross United States 11 463 0.8× 37 0.1× 88 0.7× 214 1.9× 18 0.2× 16 763
Zhengke Li United States 15 457 0.8× 173 0.7× 98 0.8× 47 0.4× 25 0.2× 23 636
Scott J. Bornheimer United States 9 359 0.6× 77 0.3× 68 0.6× 76 0.7× 8 0.1× 17 655
Helmut Näher Germany 14 339 0.6× 290 1.1× 184 1.6× 35 0.3× 7 0.1× 30 744

Countries citing papers authored by Tessa Knox

Since Specialization
Citations

This map shows the geographic impact of Tessa Knox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tessa Knox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tessa Knox more than expected).

Fields of papers citing papers by Tessa Knox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tessa Knox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tessa Knox. The network helps show where Tessa Knox may publish in the future.

Co-authorship network of co-authors of Tessa Knox

This figure shows the co-authorship network connecting the top 25 collaborators of Tessa Knox. A scholar is included among the top collaborators of Tessa Knox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tessa Knox. Tessa Knox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Noonepalle, Satish, Christian Zevallos‐Delgado, Nima Aghdam, et al.. (2023). Abstract 900: Reprogramming macrophages with HDAC6 inhibitors for anti-cancer macrophage-based cell therapy. Cancer Research. 83(7_Supplement). 900–900. 1 indexed citations
2.
Olender, Jacqueline, Bi‐Dar Wang, Travers Ching, et al.. (2019). A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance. Molecular Cancer Research. 17(10). 2115–2125. 11 indexed citations
3.
4.
Knox, Tessa, Eva Sahakian, Debarati Banik, et al.. (2019). Abstract LB-074: Priming the tumor microenvironment with epigenetic modifiers to overcome resistance to immune checkpoint inhibitors. Cancer Research. 79(13_Supplement). LB–74. 1 indexed citations
5.
Shen, Sida, Melissa Hadley, Jiřı́ Pavlı́ček, et al.. (2019). Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models. Journal of Medicinal Chemistry. 62(18). 8557–8577. 63 indexed citations
6.
Noonepalle, Satish, Jennifer Kim, Melissa Hadley, et al.. (2018). Abstract 5126: Modulation of lactate in the tumor microenvironment with lactate transporter inhibitor in a melanoma syngeneic mouse model. Cancer Research. 78(13_Supplement). 5126–5126. 2 indexed citations
7.
Tavares, Maurício T., Sida Shen, Tessa Knox, et al.. (2017). Synthesis and Pharmacological Evaluation of Selective Histone Deacetylase 6 Inhibitors in Melanoma Models. ACS Medicinal Chemistry Letters. 8(10). 1031–1036. 25 indexed citations
8.
Banik, Debarati, Melissa Hadley, Jennifer Kim, et al.. (2017). Abstract 4854: Evaluating HDAC6 as a causal factor in metastatic breast cancer to develop immunotherapy. Cancer Research. 77(13_Supplement). 4854–4854. 1 indexed citations
9.
Powers, John J., Maritza Lienlaf, Patricio Perez-Villarroel, et al.. (2016). Expression and Function of Histone Deacetylase 10 (HDAC10) in B Cell Malignancies. Methods in molecular biology. 1436. 129–145. 6 indexed citations
10.
Lienlaf, Maritza, Patricio Perez-Villarroel, Tessa Knox, et al.. (2016). Essential role of HDAC6 in the regulation of PD‐L1 in melanoma. Molecular Oncology. 10(5). 735–750. 136 indexed citations
11.
Chen, Jie, Eva Sahakian, John J. Powers, et al.. (2016). Functional Analysis of Histone Deacetylase 11 (HDAC11). Methods in molecular biology. 1436. 147–165. 8 indexed citations
12.
Knox, Tessa, Maritza Lienlaf, Patricio Pérez, et al.. (2016). Abstract 2331: HDAC6, new role as master regulator of PD-L1 and immune-related pathways. Cancer Research. 76(14_Supplement). 2331–2331. 1 indexed citations
13.
Lienlaf, Maritza, Patricio Perez-Villarroel, Calvin Lee, et al.. (2014). Abstract 4089: Histone deacetylase 6 (HDAC6) as a regulator of PD-L1 expression through STAT3 modulation in melanoma. Cancer Research. 74(19_Supplement). 4089–4089. 1 indexed citations
14.
Powers, John J., Eva Sahakian, Limin Xing, et al.. (2014). Histone Deacetylase 6 (HDAC6) As a Regulator of Immune Check-Point Molecules in Chronic Lymphocytic Leukemia (CLL). Blood. 124(21). 3311–3311. 10 indexed citations
15.
Cheng, Fengdong, Maritza Lienlaf, Patricio Perez-Villarroel, et al.. (2014). Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells. Molecular Immunology. 60(1). 44–53. 113 indexed citations
16.
Lienlaf, Maritza, Patricio Perez-Villarroel, Fengdong Cheng, et al.. (2013). Role Of Histone Deacetylase 6 (HDAC6) In The Modulation Of STAT Pathways and Immune Function Of APCs. Blood. 122(21). 1032–1032. 1 indexed citations
17.
Gorbatyuk, Marina S., Tessa Knox, Matthew M. LaVail, et al.. (2010). Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78. Proceedings of the National Academy of Sciences. 107(13). 5961–5966. 233 indexed citations
18.
Jacobson, Denise L., Tessa Knox, Donna Spiegelman, et al.. (2005). Prevalence of, Evolution of, and Risk Factors for Fat Atrophy and Fat Deposition in a Cohort of HIV-Infected Men and Women. Clinical Infectious Diseases. 40(12). 1837–1845. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunnie Wong Breakdown of academic impact, for papers by Rita Bisogni Breakdown of academic impact, for papers by Erin L. Filbert Breakdown of academic impact, for papers by Martha Delahunty Breakdown of academic impact, for papers by Manuela Bragardo Breakdown of academic impact, for papers by N. J. Philpott Breakdown of academic impact, for papers by E A Gross Breakdown of academic impact, for papers by Zhengke Li Breakdown of academic impact, for papers by Scott J. Bornheimer Breakdown of academic impact, for papers by Helmut Näher
Rankless by CCL
2026